Pentixapharm Extends Convertible Bond to 2030
Pentixapharm and Eckert & Ziegler's Extended Bond Play Fresh off the Berlin newswire, Pentixapharm Holding AG made a bold move with Eckert & Ziegler SE (EZAG). This isn't your everyday handshake, folks. We're talking about extending a 4.00% convertible bond from 2027 all the way out to 2030. There's a twist: the interest rate's ticking up to 6.00% starting in 2027. So,...
Continue Reading